Key Insights

Highlights

Treatment Research

3 treatments under study, led by Amoxicillinclavulanate 875mg125mg Q12hrs

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Enrolling By Invitation1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07177378Not ApplicableEnrolling By InvitationPrimary

Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure

NCT05867654Phase 4UnknownPrimary

Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial Osteomyelitis

Showing all 2 trials

Research Network

Common Treatments

  • Amoxicillinclavulanate 875mg125mg Q12hrs1
  • Levofloxacin1
  • Management Of Medication Related Osteonecrosis Of The Jaw1

Active Sponsors

  • Osteo Science Foundation1
  • University of Louisville1
  • Tanta University1

Activity Timeline